{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:55:48Z","timestamp":1780761348146,"version":"3.54.1"},"reference-count":34,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2000,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Genetic immunization is a promising new technology for developing vaccines against tuberculosis that are more effective. In the present study, we evaluated the effects of intracellular turnover of antigens expressed by DNA vaccines on the immune response induced by these vaccines in a mouse model of pulmonary tuberculosis. The mycobacterial culture filtrate protein MPT64 was expressed as a chimeric protein fused to one of three variants of the ubiquitin protein (UbG, UbA, and UbGR) known to differentially affect the intracellular processing of the coexpressed antigens. Immunoblot analysis of cell lysates of in vitro-transfected cells showed substantial differences in the degradation rate of ubiquinated MPT64 (i.e., UbG64 &lt; UbA64 &lt; UbGR64). The specific immune response generated in mice correlated with the stability of the ubiquitin-conjugated antigen. The UbA64 DNA vaccine induced a weak humoral response compared to UbG64, and a mixed population of interleukin-4 (IL-4)- and gamma interferon (IFN-\u03b3)-secreting cells. Vaccination with the UbGR64 plasmid generated a strong Th1 cell response (high IFN-\u03b3, low IL-4) in the absence of a detectable humoral response. Aerogenic challenge of vaccinated mice with<jats:italic>Mycobacterium tuberculosis<\/jats:italic>indicated that immunization with both the UbA64- and UbGR64-expressing plasmids evoked an enhanced protective response compared to the vector control. The expression of mycobacterial antigens from DNA vaccines as fusion proteins with a destabilizing ubiquitin molecule (UbA or UbGR) shifted the host response toward a stronger Th1-type immunity which was characterized by low specific antibody levels, high numbers of IFN-\u03b3-secreting cells, and significant resistance to a tuberculous challenge.<\/jats:p>","DOI":"10.1128\/iai.68.6.3097-3102.2000","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:19Z","timestamp":1027764079000},"page":"3097-3102","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":84,"title":["DNA Vaccination against Tuberculosis: Expression of a Ubiquitin-Conjugated Tuberculosis Protein Enhances Antimycobacterial Immunity"],"prefix":"10.1128","volume":"68","author":[{"given":"Giovanni","family":"Delogu","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Howard","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"Collins","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheldon L.","family":"Morris","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.6.2951-2959.1998"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4049\/jimmunol.157.8.3527","article-title":"Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis","volume":"157","author":"Brandt L.","year":"1996","unstructured":"Brandt L. Oettinger T. Holm A. Andersen A. B. Andersen P. Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis.J. Immunol.157199635273533","journal-title":"J. Immunol."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00522.x"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510330076038"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0041-3879(85)90064-9"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.4049\/jimmunol.163.9.4721","article-title":"In vivo priming by DNA injection occurs predominantly by antigen transfer","volume":"163","author":"Corr M.","year":"1999","unstructured":"Corr M. von Damm A. Lee D. J. Tighe H. In vivo priming by DNA injection occurs predominantly by antigen transfer.J. Immunol.163199947214727","journal-title":"J. Immunol."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.15.1.617"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)00134-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401683"},{"key":"e_1_3_2_11_2","unstructured":"Germain R. N. Antigen processing and presentation Fundamental immunology. Paul W. E. 1999 287 340 Lippincott-Raven Bethesda Md"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-893"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.4049\/jimmunol.162.7.3915","article-title":"Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes","volume":"162","author":"Ishioka G. Y.","year":"1999","unstructured":"Ishioka G. Y. Fikes J. Hermanson G. Livingston B. Crimi C. Qin M. del Guercio M. F. Oseroff C. Dahlberg C. Alexander J. Chesnut R. W. Sette A. Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes.J. Immunol.162199939153925","journal-title":"J. Immunol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1999.00703.x"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058699"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","unstructured":"Klinman D. M. ELISPOT assay to detect cytokine-secreting murine and human cells Current protocols in immunology. Coligan J. E. Kruisbeek A. M. Marguiles D. H. Shevach E. M. Struber W. 1994 6.19.1 6.19.8 Wiley Interscience New York N.Y","DOI":"10.1002\/0471142735.im0619s10"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.9.4780-4786.1999"},{"key":"e_1_3_2_18_2","first-page":"285","article-title":"Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA","volume":"43","author":"Montgomery D. L.","year":"1997","unstructured":"Montgomery D. L. Huygen K. Yawman A. M. Deck R. R. DeWitt C. M. Content J. Liu M. A. Ulmer J. B. Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA.Cell Mol. Biol.431997285292","journal-title":"Cell Mol. Biol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(99)00540-X"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1086\/515374"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70049-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01438-8"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1997.62"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.11.8497-8503.1997"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.3.841"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00188611"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/334255a0"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-888"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.5.909"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.22.12142"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5388.476"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.9.4208-4214.1998"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.4049\/jimmunol.161.5.2325","article-title":"A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine","volume":"161","author":"Weiss W. R.","year":"1998","unstructured":"Weiss W. R. Ishii K. J. Hedstrom R. C. Sedegah M. Ichino M. Barnhart K. Klinman D. M. Hoffman S. L. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.J. Immunol.161199823252332","journal-title":"J. Immunol."},{"key":"e_1_3_2_34_2","unstructured":"World Health Organization Global Tuberculosis Control WHO Report 1999. 1999 World Health Organization Geneva Switzerland"},{"key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.4049\/jimmunol.159.12.6037","article-title":"Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome- dependent degradation are highly efficient inducers of cytolytic T lymphocytes","volume":"159","author":"Wu Y.","year":"1997","unstructured":"Wu Y. Kipps T. J. Deoxyribonucleic acid vaccines encoding antigens with rapid proteasome- dependent degradation are highly efficient inducers of cytolytic T lymphocytes.J. Immunol.159199760376043","journal-title":"J. Immunol."}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.6.3097-3102.2000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.68.6.3097-3102.2000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:19:19Z","timestamp":1682263159000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.68.6.3097-3102.2000"}},"subtitle":[],"editor":[{"given":"S. H. E.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["10.1128\/IAI.68.6.3097-3102.2000"],"URL":"https:\/\/doi.org\/10.1128\/iai.68.6.3097-3102.2000","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"1999-09-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-02-25","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2000-06-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}